RheumaGen

Series-A
rheumagen.com Biotech & Healthcare Aurora, United States
Total Funding $15M
Latest Round Undisclosed Series-A
Last Announced Dec 22, 2025
Investors 3 Backers
Decision Makers Profile Active

About RheumaGen

RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Aurora, United States
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website rheumagen.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $15,000,000 · Series-A

    fundraisingfox.com

Investors & Backers

3
Beyond Celiac Investments
SPRIM Global Investments
William Taylor Nominees

Funding History

2 Rounds
Series-A equity · Dec 22, 2025
Series-A equity · Jan 9, 2025

Founders & Leadership

3

Brian Freed

Chief Science Officer & Co-Founder

Work email & phone locked Unlock →

Brian Hart

COO & Co-Founder

Work email & phone locked Unlock →

Richard Freed

CEO & Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts